Introduction {#s1}
============

Inflammatory bowel disease (IBD), a chronic inflammatory disease of the gastrointestinal tract, is usually classified into two clinical forms: Crohn's disease (CD) and ulcerative colitis (UC) \[[@B1],[@B2]\]. CD generally involves the ileum and colon, and it can affect any region of the intestine in a continuous manner. UC involves the rectum and may affect part of the colon or the entire colon, often uninterruptedly. The etiology of IBD most likely involves a complex interaction of genetic and environmental factors. Although the etiology remains poorly understood, epidemiologic and linkage studies suggest that genetic factors are implicated in the pathogenesis of IBD \[[@B3]-[@B9]\].

Recent progress in the genetics of IBD has advanced understanding of disease pathogenesis. GWAS meta-analysis identified 71, 47 and 163 susceptibility loci of CD, UC and IBD, respectively. These genes involved in intestinal barrier function (GNA12 and LAMB1), transcriptional regulation (NKX2-3 and IRF5) and immune response (IL23R and IL12B). Recently, studies in animal models and IBD patients suggested that autophagy related genes (*ATG16L1* and *IRGM*) may play an important role in the pathogenesis of IBD\[[@B10]--[@B12]\]. The immunity-related GTPase family M (*IRGM*) gene, located on chromosome 5q33.1, encodes a GTP-binding protein that induces autophagy, which is involved in elimination of intracellular pathogens\[[@B13],[@B14]\]. Association of three common polymorphisms in *IRGM* gene (rs13361189, rs4958847 and rs10065172) with IBD has been recently reported \[[@B12],[@B15]-[@B18]\]. However, the genetic association studies that investigated the association between IBD and rs13361189, rs4958847 or rs10065172 variant have produced inconclusive results. For instance, an accumulating number of studies suggested a positive association between *IRGM* polymorphisms and CD susceptibility \[[@B12],[@B18],[@B19]\], which, nevertheless, could not be replicated in several studies \[[@B16],[@B20],[@B21]\]. This inconsistency may be due to studies with limited sample sizes, inadequate statistical power, or ethnic differences.

Meta-analysis is a proper method to deal with these ambiguities and overcome the problem of small sample sizes and inadequate statistical power in different genetic studies. In the present study, we performed a meta-analysis of all eligible case control and cohort studies to clarify the associations between three common polymorphisms (rs13361189, rs4958847 and rs10065172) in the *IRGM* gene and IBD (CD or UC) susceptibility.

Materials and Methods {#s2}
=====================

Identification and eligibility of relevant studies {#s2.1}
--------------------------------------------------

Electronic searches in Medline, Embase, CNKI (China National Knowledge Infrastructure) and Chinese Biomedicine databases were performed using the following search terms: 'Inflammatory Bowel Disease' or 'IBD', 'Crohn's disease' or 'CD', 'ulcerative colitis' or 'UC', '*IRGM*', 'polymorphism' or 'variant', 'rs13361189', 'rs4958847' or 'rs10065172', and 'single nucleotide polymorphism' or 'SNP'( the last search update was 5 June 2013). In addition, the reference lists of all retrieved articles were checked for additional potential studies. A study was included in the analysis if (1) reported the relationship between the polymorphisms of IRGM rs13361189, rs4958847 or rs10065172and the risk of IBD; (2) the genetic information of included studies was from unrelated populations (studies of which the design was not based on family data). Major reasons for exclusion of studies: (1) no control population; (2) studies that contained overlapping data; (3) comments, letters, review articles, or articles only with an abstract. Additionally, when a study reported the results on different subpopulations or panels, we treated them as separate studies in the meta-analysis.

Data extraction {#s2.2}
---------------

The following data was extracted independently from each study by two authors: first author, journal, year of publication, country of origin, ethnicity of the individuals involved (Europeans, Asians, or Africans), genotype frequency, sex and mean age in cases and controls. Of the studies with the overlapping data of the same population resource, we selected the most recent ones with the largest number of participants. If the article did not provide sufficient genotype distribution, the corresponding author was contacted for the detailed data. In addition, disagreements were resolved by discussion between the two investigators.

Statistical analysis {#s2.3}
--------------------

The strength of the association between *IRGM* polymorphisms and CD or UC risk was evaluated by the odds ratios (ORs) with 95% confidence intervals (CIs). For the rs13361189 polymorphism, we examined the allelic effect of C (minor allele) versus T (common allele), and also examined the contrast of CC versus TT, CT versus TT, CC+CT versus TT (dominant model), as well as CC versus CT+TT (recessive model). Similar models were analyzed for the rs4958847 and rs10065172 polymorphisms. The association between rs10065172 and UC risk was not evaluated for the lack of sufficient data. The significance of the pooled OR was determined by the Z-test; and the P values were adjusted using Bonferroni correction by the number of compared SNPs. (P=0.05/3=0.017) In addition, for each genetic contrast, stratified analysis was performed according to ethnicity. The Hardy-Weinberg equilibrium (HWE) in the control group was assessed, and P\<0.05 was considered as significant disequilibrium.

The heterogeneity between studies was assessed by Chi-square based Q test \[[@B22]\] and I^2^ test. Heterogeneity was considered significant when P\<0.10, and then the random effect model was applied for meta-analysis, otherwise, a fixed-effects model was used \[[@B23]\]. I^2^ takes values between 0% and 100% with higher values denoting a greater degree of heterogeneity \[[@B24]\]. In addition, a meta-regression model was performed to explore the possible heterogeneity among different kinds of studies.

Cumulative meta-analyses were carried out for all three variants in association with CD and two variants (rs13361189 and rs4958847) with UC to evaluate the trend of the genetic risk effect (OR) of the allele contrast as evidence accumulating over time. To assess the stability of the results, sensitivity analysis was carried out after sequential removal of each study or by excluding those studies deviated from HWE.

Publication bias was investigated using graphical evaluation of funnel plots. However, the funnel plot may be not considered strictly as a test of publication bias. Then, the Egger's test was used to provide statistical evidence of funnel plot symmetry \[[@B25]\]. If significant publication bias was detected, ORs and 95% CIs would be adjusted by trim and fill methods. All statistical analyses were performed by STATA software (version 12).

Results {#s3}
=======

Main characteristics of eligible studies {#s3.1}
----------------------------------------

The literature review identified 62 articles in PubMed, Embase, CNKI and Chinese Biomedicine databases that met the search criteria. The abstracts and full articles of the retrieved studies were read to assess their appropriateness for meta-analysis. Finally, a total of 23 relevant articles with *IRGM* polymorphisms (rs13361189, rs4958857 or rs10065172) and IBD (UC or CD) were included in this meta-analysis. [Figure 1](#pone-0080602-g001){ref-type="fig"} showed a flow chart of the retrieved studies and the excluded studies. Among them, one publication \[[@B16]\] contained data on two different subpopulations, one \[[@B18]\] included Wellcome Trust Case Control Consortium (WTCCC) samples and replication Crohn\'s disease (RCD) samples and we treated them independently. Therefore, 25 studies that comprised a total of 20590 IBD cases and 27670 controls were considered in our meta-analysis.

![Flowchart of search strategy for meta-analysis.](pone.0080602.g001){#pone-0080602-g001}

A list of details of the studies included in the meta-analysis was provided in [Table 1](#pone-0080602-t001){ref-type="table"}. The studies were published from 2007 to 2013. Studies were conducted in various populations of ethnic descent: 17 Europeans \[[@B12],[@B15]-[@B19],[@B21],[@B26]-[@B35]\], 4 Asians \[[@B36]--[@B39]\], 1 Africans \[[@B20]\] and 1 Jewishs \[[@B40]\]. Because of the insufficient samples available for African and Jewish groups, we have performed subgroup analysis in Europeans and Asians. Although the allele frequency of the *IRGM* polymorphisms was extracted from 25 studies, 4 studies \[[@B19],[@B28],[@B30],[@B31]\] did not include genotype distributions, but one \[[@B19]\] was included after we contacted the authors directly, who provided sufficient data. In 2 studies \[[@B18],[@B21]\], the distribution of the genotypes in control group was not in HWE (P\<0.05). Then, a sensitivity analysis was performed by excluding these studies from the analysis.

10.1371/journal.pone.0080602.t001

###### Characteristics of Studies Included in the Meta-analysis.

                                                                         Cases                        Controls                                                                   
  ----------------------- ---------- ------------ ---------------------- ----------------- ---------- ------------------------------------------ -- ------ ------ -------------- -------------
  Wang, 2012              African    rs13361189   CD                     CD:354            34.2       37.4±14.3 and 26.7±12.9 at diagnosis          354    42.6   39.8±12.7      nr
                                     rs4958847                                                                                                                                   
                                     rs10065172                                                                                                                                  
  Meggyesi1, 2010         European   rs13361189   CD and UC separately   CD: 456 UC: 274   CD:53.6    CD: 37.1±12.6 and 26.5±10.6 at diagnosis      271    nr     nr             Age and sex
  Meggyesi2, 2010         European   rs13361189   CD and UC separately   CD:352 UC: 154    UC:47.2    UC: 43.7±15.0 and 31.3±13.4 at diagnosis      198    nr     nr             
  Peter, 2011             Jewish     rs13361189   CD                     CD:369            nr         nr                                            503    nr     nr             nr
  Dema, 2009              European   rs4958847    CD                     CD:725            nr         nr                                            956    nr     nr             nr
                                     rs10065172                                                                                                                                  
  Frank, 2008             European   rs13361189   CD and UC separately   CD: 1850          CD:32      CD: 38 and 21 at diagnosis (median)           1817   nr     nr             Age and sex
                                     rs4958847                           UC: 1103          UC:42.8    UC: 40 and 26 at diagnosis (median)                                        
                                     rs10065172                                                                                                                                  
  Wolfkamp, 2010          European   rs13361189   CD                     CD: 530           nr         nr                                            529    nr     nr             nr
                                     rs4958847                                                                                                                                   
  Palomino-Morales,2009   European   rs13361189   CD and UC separately   CD: 557           nr         nr                                            672    nr     nr             Age and sex
                                     rs4958847                           UC: 425                                                                                                 
  Yamazaki, 2009          Asian      rs13361189   CD                     CD: 484           72.5       22.4(7--55)                                   470    50.2   38.7(21--77)   nr
                                     rs4958847                                                                                                                                   
  Prager, 2012            European   rs13361189   CD and UC separately   CD: 464           CD:37.5    CD:29.5±11.6 at diagnosis                     508    42     60±16.2        nr
                                     rs4958847                           UC: 292           UC:44.8    UC:34.3±14.2 at diagnosis                                                  
  Fisher, 2008            European   rs13361189   UC                     UC: 1841          nr         nr                                            1470   nr     nr             nr
                                     rs4958847                                                                                                                                   
  Parkes (RCD), 2007      European   rs13361189   CD                     CD:1182           40.3       CD: 43.9 and 25.5 at diagnosis (median)       2024   nr     nr             nr
                                     rs4958847                                                                                                                                   
  Parkes (WTCCC), 2007    European   rs13361189   CD                     CD:1748           39.2       CD: 45.7 and 26.1 at diagnosis (median)       8655   nr     nr             nr
                                     rs4958847                                                                                                                                   
  Roberts, 2009           European   rs13361189   CD and UC separately   CD: 507           nr         nr                                            576    nr     nr             nr
                                     rs4958847                           UC: 475                                                                                                 
  Latiano, 2009           European   rs4958847    CD and UC separately   CD: 823                      CD: 30 ± 15 at diagnosis                      578    nr     nr             nr
                                                                         UC: 353                      UC: 25 ± 16 at diagnosis                                                   
  Zheng, 2012             Asian      rs13361189   CD                     CD:318            48.4       CD: 37.2±11.4                                 318    49.1   36.7±12.3      nr
  Prescott, 2010          European   rs13361189   CD                     CD:1848           nr         nr                                            2025   nr     nr             nr
                                     rs10065172                                                                                                                                  
  Pang, 2011              Asian      rs13361189   CD                     CD:66             48.5       CD:36.3±11.8                                  66     50.0   35.4±13.1      nr
  Limbergen, 2009         European   rs13361189   CD                     CD:630            nr         nr                                            3283   nr     nr             nr
                                     rs4958847                                                                                                                                   
                                     rs10065172                                                                                                                                  
  Weersma, 2009           European   rs13361189   CD and UC separately   CD: 1656          nr         nr                                            1086   nr     nr             nr
                                     rs4958847                           UC: 1075                                                                                                
  Eglinton, 2012          European   rs4958847    CD                     CD: 507           37.1       45±17.9                                       507    nr     nr             nr
  Amre, 2009              European   rs10065172   CD                     CD: 289           55.4       CD: 12.1± 3.5 at diagnosis                    290    52.4   11.4± 6.8      nr
  Duraes, 2013            European   rs13361189   CD                     CD: 511           46.2       CD: 28.6± 11.2 at diagnosis                   626    38.5   30.5(9-83)     sex
  Glas, 2013              European   rs13361189   CD and UC separately   CD: 817           CD: 46.0   CD: 40.7±13.3 and 27.9±12.0 at diagnosis      961    63.6   47.4±9.06      nr
                                     rs4958847                           UC: 283           UC: 53.0   UC: 43.8±14.4 and 31.3±13.7 at diagnosis                                   
                                     rs10065172                                                                                                                                  
  Moon, 2013              Asian      rs4958847    CD and UC separately   CD: 253           CD:60.9    CD:25.9±10.4 at diagnosis                     520    56.5   39.3±15.8      Age and sex
                                     rs10065172                          UC: 257           UC:50.6    UC:37.1±12.4 at diagnosis                                                  

CD: Crohn's disease, UC: ulcerative colitis, nr: not report.

Quantitative synthesis {#s3.2}
----------------------

### Crohn's disease {#s3.2.1}

The relevant studies included 38369 individuals (13043 cases and 25326 controls) for rs13361189 variant, 34397 individuals (10924 cases and 23473 controls) for rs4958847 variant, and 16972 individuals (6766 cases and 10206 controls) for rs10065172 variant. We observed a wide spectrum of the rs13361189 C allele and rs4958847 A allele frequencies across different ethnicities. Compared with Europeans controls (8.32%, 95% CI=7.07-9.58), Asian controls carried a higher frequency (35.37%, 95%CI= 31.13-39.60; p=2.5×10^-13^) of rs13361189 C allele. Similar result was observed in rs4958847 (p=1.8×10^-10^). For rs10065172 variant, as only one study carried out in Asians was included, one sample T-test was used to compare the differences of allele frequencies between Asian and European controls (p=9.9×10^-7^). ([Figure 2](#pone-0080602-g002){ref-type="fig"})

![Allele frequencies (%) in the three major ethnical groups in controls of CD to (A) rs13361189, (B) rs4958847 and (C) rs10065172.\
Each data point represents a separate study for the indicated association. Horizontal line represents the mean value.](pone.0080602.g002){#pone-0080602-g002}

[Table 2](#pone-0080602-t002){ref-type="table"} showed the meta-analysis results of the association between the allele contrast and genetic models of the different gene polymorphisms and the risk of CD. Significantly elevated CD risk was associated with rs13361189, rs4958847 or rs10065172 for the allele contrast. (OR=1.306 (1.200-1.420), p=5.2×10^-10^, OR=1.182 (1.082-1.290), p=0.0002 and OR=1.248 (1.057-1.473), p=0.009 respectively, significant even after Bonferroni correction). Moreover, significant correlation was also found in the three polymorphisms under other genetic models (homozygote, heterozygote, dominant and recessive models). ([Table 2](#pone-0080602-t002){ref-type="table"}, [Figure 3](#pone-0080602-g003){ref-type="fig"})

10.1371/journal.pone.0080602.t002

###### Pooled analysis for the associations between the polymorphism of IRGM and the risk of Crohn's disease.

  Variant      Comparison      Variables    Data NO.   Sameple Size   Test of association   Model   Test of heterogeneity                              
  ------------ --------------- ------------ ---------- -------------- --------------------- ------- ----------------------- --------------- --- ------ ---------
  rs13361189   C *vs* T        Overall      18         13043          25326                         1.306 (1.200-1.420)     5.2×10^-10^\*   R   55.5   0.002
                               Europeans    13         11806          24118                         1.396 (1.314-1.483)     4.2×10^-27^\*   F   35.2   0.101
                               Asians       3          868            854                           1.084 (0.942-1.248)     0.26            F   0.00   0.984
                               All in HWE   15         9483           11364                         1.300(1.169-1.446)      1.4×10^-6^\*    R   62.5   0.001
               CC *vs* TT      Overall      17         12413          22043                         1.565 (1.218-2.010)     0.0004\*        R   38.7   0.053
                               Europeans    12         11176          20835                         2.042 (1.581-2.638)     4.6×10^-8^\*    F   11.1   0.336
                               Asians       3          868            854                           1.064 (0.781-1.450)     0.695           F   0.00   0.763
                               All in HWE   15         9483           11364                         1.636 (1.220-2.193)     0.001\*         R   45.8   0.027
               CT *vs* TT      Overall      17         12413          22043                         1.360 (1.279-1.448)     2.8×10^-22^\*   F   27.8   0.138
                               Europeans    12         11176          20835                         1.390 (1.298-1.488)     3.2×10^-21^\*   F   21.5   0.232
                               Asians       3          868            854                           1.239 (1.010-1.520)     0.040           F   0.00   0.550
                               All in HWE   15         9483           11364                         1.320 (1.198-1.454)     1.9×10^-8^\*    R   34.9   0.090
               CC+CT *vs* TT   Overall      17         12413          22043                         1.362 (1.255-1.479)     1.3×10^-13^\*   R   37.3   0.061
                               Europeans    12         11176          20835                         1.421 (1.329-1.519)     5.0×10^-25^\*   F   29.7   0.155
                               Asians       3          868            854                           1.199 (0.987-1.455)     0.068           F   0.00   0.816
                               All in HWE   15         9483           11364                         1.345 (1.214-1.489)     1.3×10^-8^\*    R   44.6   0.032
               CC *vs* CT+TT   Overall      17         12413          22043                         1.448 (1.129-1.856)     0.004\*         R   41.5   0.038
                               Europeans    12         11176          20835                         1.919 (1.486-2.447)     5.7×10^-7^\*    F   9.40   0.353
                               Asians       3          868            854                           0.941 (0.705-1.256)     0.682           F   0.00   0.478
                               All in HWE   15         9483           11364                         1.506 (1.128-2.012)     0.006\*         R   48.3   0.019
  rs4958847    A *vs* G        Overall      14         9854           21892                         1.182 (1.082-1.290)     0.0002\*        R   66.6   0.0002
                               Europeans    11         9016           21068                         1.228 (1.117-1.349)     0.00002\*       R   64.0   0.002
                               Asians       2          737            970                           1.062(0.925-1.220)      0.395           F   33.6   0.220
                               All in HWE   11         7578           19398                         1.195 (1.076-1.328)     0.001\*         R   72.1   0.00009
               AA *vs* GG      Overall      13         9224           18609                         1.312 (1.045-1.647)     0.019           R   55.7   0.008
                               Europeans    10         8386           17785                         1.449 (1.084-1.936)     0.012\*         R   55.6   0.016
                               Asians       2          737            970                           1.120 (0.844-1.485)     0.434           F   24.2   0.251
                               All in HWE   11         7578           19398                         1.373 (1.057-1.783)     0.017           R   61.6   0.004
               AG *vs* GG      Overall      13         9224           18609                         1.205 (1.097-1.323)     0.0001\*        R   51.2   0.017
                               Europeans    10         8386           17785                         1.251 (1.138-1.376)     3.8×10^-6^\*    R   49.5   0.037
                               Asians       2          737            970                           0.986 (0.766-1.268)     0.911           F   0.00   0.426
                               All in HWE   11         7578           19398                         1.192 (1.071-1.326)     0.001\*         R   54.6   0.015
               AA+AG *vs* GG   Overall      13         9224           18609                         1.220 (1.106-1.347)     0.00007\*       R   59.1   0.004
                               Europeans    10         8386           17785                         1.269 (1.147-1.403)     3.6×10^-6^\*    R   58.1   0.011
                               Asians       2          737            970                           1.028 (0.810-1.304)     0.820           F   12.9   0.284
                               All in HWE   11         7578           19398                         1.216 (1.085-1.363)     0.001\*         R   63.4   0.002
               AA *vs* AG+GG   Overall      13         9224           18609                         1.248 (1.028-1.515)     0.025           R   48.7   0.025
                               Europeans    10         8386           17785                         1.367 (1.037-1.802)     0.026           R   51.7   0.028
                               Asians       2          737            970                           1.132 (0.912-1.406)     0.260           F   0.00   0.402
                               All in HWE   11         7578           19398                         1.300 (1.043-1.619)     0.019           R   55.1   0.014
  rs10065172   T vs C          Overall      8          5407           8435                          1.248 (1.057-1.473)     0.009\*         R   79.4   0.00002
                               Europeans    6          5053           8081                          1.284 (1.055-1.564)     0.013           R   80.3   0.0001
               TT vs CC        Overall      7          4777           5152                          1.543 (1.078-2.207)     0.018           R   48.9   0.068
                               Europeans    5          4423           4798                          1.717 (1.197-2.464)     0.003\*         F   12.6   0.334
               TC vs CC        Overall      7          4777           5152                          1.244 (1.012-1.530)     0.038           R   78.3   0.0001
                               Europeans    5          4423           4798                          1.271 (0.988-1.636)     0.062           R   83.2   0.00009
               TT+TC vs CC     Overall      7          4777           5152                          1.273 (1.030-1.573)     0.025           R   80.6   0.00003
                               Europeans    5          4423           4798                          1.298 (1.008-1.673)     0.043           R   84.1   0.00004
               TT vs TC+CC     Overall      7          4777           5152                          1.335 (1.078-1.653)     0.008\*         F   33.4   0.173
                               Europeans    5          4423           4798                          1.668 (1.162-2.393)     0.006\*         F   0.00   0.463

F: fixed-model; R: random model; \*: P value significant even after Bonferroni correction by 3 comparisons (ie 3 compared SNPs, P=0.05/3=0.017); HWE: Hardy-Weinberg equilibrium.

![OR estimates with the corresponding 95% CI for the associations between IRGM polymorphisms ((A) rs13361189, (B) rs4958847, and (C) rs10065172) and the risk of CD (dominant model).\
The sizes of the squares reflect the weighting of included studies; the centre of diamonds reflect summary effect, the left and right extremes of diamonds reflect 95% confidence intervals; CI, confidence interval; OR, odds ratio.](pone.0080602.g003){#pone-0080602-g003}

In the subgroup analysis by ethnicity, for rs13361189 T\>C, significantly increased CD risk was found among European populations in the allelic and all genetic models. (CC+CT vs TT: OR=1.421 (1.329-1.519), p=5.0×10^-25^, significant after Bonferroni correction) However, these associations were not observed in the Asian populations (CC+CT vs TT: OR=1.199 (0.987-1.455), p=0.068). Similarly, statistical association was observed between rs4958847 or rs10065172 variant and CD risk among European population. (AA+AG vs GG: OR=1.269 (1.147-1.403), p=3.6×10^-6^, still significant after Bonferroni correction) and TT+TC vs TT: OR=1.298 (1.008-1.673), p=0.043, non-significant after Bonferroni correction) In addition, the OR for rs13361189 T\>C was 1.565 (1.218-2.010) in carriers of two risk C alleles compared with non-risk allele carriers (CC vs TT), which was higher than the risk of one T allele carriers (CT vs TT, OR= 1.360 (1.279-1.448)), suggesting a dose--response with increasing number of the variant allele. The same pattern was seen for either rs4958847 or rs10065172 variant.

### Ulcerative colitis {#s3.2.2}

Meta-analysis findings of associations between rs13361189 and rs4958847 in the *IRGM* gene and the risk of UC were shown in [Table 3](#pone-0080602-t003){ref-type="table"}. A total of 4847 (5029) UC patients and 6473 (7202) controls for rs13361189 (rs4958847) polymorphism were investigated. No significant association was observed between the polymorphism of rs13361189 and the risk of UC in all comparisons (C vs T: OR=1.088 (0.989-1.198); p=0.083, CC vs TT: OR=1.428 (0.959-2.126), p=0.079; CT vs TT: OR=1.062 (0.955-1.180), p=0.266; dominant model: OR=1.079 (0.973-1.197), p=0.149; and recessive model: OR=1.395 (0.938-2.075), p=0.100.) ([Figure S1](#pone.0080602.s002){ref-type="supplementary-material"}) Similarly, for rs4955847 variant and UC risk, no obvious association was observed in allelic and genetic models. ([Figure S1](#pone.0080602.s002){ref-type="supplementary-material"}, [Table 3](#pone-0080602-t003){ref-type="table"})

10.1371/journal.pone.0080602.t003

###### Pooled analysis for the associations between the polymorphisms of IRGM and the risk of ulcerative colitis.

  Variant      Comparison      Ethnicity             Data NO.   Sample Size   Test of association   Model   Test of heterogeneity                      
  ------------ --------------- --------------------- ---------- ------------- --------------------- ------- ----------------------- ------- --- ------ -------
  rs13361189   C *vs* T        Overall (Europeans)   8          4564          5512                          1.088 (0.989-1.198)     0.083   F   0.00   0.462
               CC *vs* TT      Overall (Europeans)   8          4564          5512                          1.428 (0.959-2.126)     0.079   F   5.90   0.385
               CT *vs* TT      Overall (Europeans)   8          4564          5512                          1.062 (0.955-1.180)     0.266   F   0.00   0.459
               CC+CT *vs* TT   Overall (Europeans)   8          4564          5512                          1.079 (0.973-1.197)     0.149   F   0.00   0.456
               CC *vs* CT+TT   Overall (Europeans)   8          4564          5512                          1.395 (0.938-2.075)     0.100   F   7.60   0.372
  rs4958847    A *vs* G        Overall               8          4489          5621                          1.031 (0.955-1.112)     0.438   F   0.50   0.425
                               Europeans             7          4232          5101                          1.023 (0.943-1.109)     0.590   F   11.3   0.343
                               All in HWE            7          4197          5113                          1.028 (0.950-1.112)     0.491   F   13.9   0.324
               AA *vs* GG      Overall               8          4489          5621                          1.195 (0.937-1.525)     0.151   F   0.00   0.863
                               Europeans             7          4232          5101                          1.142 (0.860-1.518)     0.359   F   0.00   0.821
                               All in HWE            7          4197          5113                          1.250 (0.973-1.607)     0.081   F   0.00   0.975
               AG *vs* GG      Overall               8          4489          5621                          1.075 (0.921-1.254)     0.361   R   59.9   0.015
                               Europeans             7          4232          5101                          1.039 (0.894-1.208)     0.621   R   56.7   0.031
                               All in HWE            7          4197          5113                          1.057 (0.895-1.248)     0.514   R   62.7   0.013
               AA+AG *vs* GG   Overall               8          4489          5621                          1.066 (0.935-1.215)     0.343   R   48.0   0.062
                               Europeans             7          4232          5101                          1.015 (0.927-1.111)     0.751   F   43.6   0.100
                               All in HWE            7          4197          5113                          1.058 (0.916-1.222)     0.446   R   53.6   0.044
               AA *vs* AG+GG   Overall               8          4489          5621                          1.053 (0.852-1.302)     0.631   F   0.00   0.747
                               Europeans             7          4232          5101                          1.137 (0.857-1.508)     0.375   F   0.00   0.727
                               All in HWE            7          4197          5113                          1.086 (0.875-1.348)     0.445   F   0.00   0.848

F: fixed-model; R: random model; HWE: Hardy-Weinberg equilibrium.

Test of heterogeneity {#s3.3}
---------------------

There was significant heterogeneity in most comparisons of three *IRGM* SNPs in the total analysis of CD. ([Table 2](#pone-0080602-t002){ref-type="table"}) Then meta-regression was carried out to assess the source of heterogeneity for dominant model comparison by year of publication, ethnicity and sample size (individuals more than 500 in both cases and controls). The results showed that ethnicity could explain 41.37% and 19.77% of the τ^2^ in rs13361189 and rs4958847 variants, respectively. Moreover, sample size could explain 63.28% of τ^2^ under dominant model in rs13361189 variant. However, for rs10065172 variant, meta-regression analyses did not show any sources that contribute to the substantial heterogeneity.

Sensitivity analyses and cumulative meta-analysis {#s3.4}
-------------------------------------------------

Sensitivity analyses indicated that the pooled ORs were consistently significant in CD by omitting one study at a time, suggesting robustness of our results. ([Figure 4](#pone-0080602-g004){ref-type="fig"}, [Figure S2](#pone.0080602.s003){ref-type="supplementary-material"}) Although there were two studies ([@B18],[@B21]) which deviated from HWE, the corresponding pooled ORs were not materially altered with or without including these two studies in all comparisons. ([Table 2](#pone-0080602-t002){ref-type="table"}, [3](#pone-0080602-t003){ref-type="table"})

![Sensitivity analysis on the associations between IRGM polymorphisms ((A) rs13361189, (B) rs4958847, and (C) rs10065172) and CD risk (dominant model).\
Results were computed by omitting each study (left column) in turn, Bars: 95% confidence interval.](pone.0080602.g004){#pone-0080602-g004}

In addition, sensitivity analyses showed that three independent studies \[[@B19],[@B21],[@B32]\] were the potential origin of heterogeneity in association between rs13361189 variant and CD risk. The heterogeneity was effectively removed by exclusion of these four studies (C vs T: Ph=0.121, CC vs TT: Ph=0.190, CT vs TT: Ph=0.700, CC+CT vs TT: Ph=0.595, and CC vs CT+TT: Ph=0.145). For rs4958847 variant, three studies \[[@B20],[@B32],[@B33]\] were responsible for the heterogeneity. The Q-test of heterogeneity was decreased or removed after exclusion of three studies: A vs G: Ph=0.086, AA vs GG: Ph=0.283, AG vs GG: Ph=0.315, AA+AG vs GG: Ph=0.259, and AA vs AG+GG: Ph=0.409. Two studies \[[@B20],[@B33]\] were the possible sources of heterogeneity of rs10065172, when excluding, the heterogeneity was removed. (T vs C: Ph=0.596, TT vs CC: Ph=0.930, TC vs CC: Ph=0.677, TT+TC vs CC: Ph=0.727, TT vs TC+CC: Ph=0.810)

In the cumulative meta-analysis, the pooled ORs tended to be stable and the associations tended toward significant with accumulation of more data over time between rs13361189, rs4958847 or rs10065172 polymorphism and CD risk. ([Figure 5](#pone-0080602-g005){ref-type="fig"}) However, [Figure S3](#pone.0080602.s004){ref-type="supplementary-material"} presented that the associations remained non-significant with accumulation of more data over time in rs13361189 or rs4958847 variant and risk of UC.

![Cumulative meta-analysis: pooled OR with the corresponding 95% CI at the end of each year information step is shown for IRGM polymorphisms ((A) rs13361189, (B) rs4958847, and (C) rs10065172) and risk of CD (dominant model).](pone.0080602.g005){#pone-0080602-g005}

Publication bias {#s3.5}
----------------

Funnel plots and Egger's test were performed to assess publication bias. The shapes of the funnel plots did not reveal evidence of obvious asymmetry in all comparison models. Then, the Egger's test was used to provide statistical evidence of funnel plot symmetry. Egger's test did not show any evidence of publication bias of rs13361189 variant (P=0.237 for CC+CT vs TT in CD, P=0.631 for CC+CT vs TT in UC), rs4958847 variant (P=0.278 for AA+AG vs GG in CD, P=0.108 for AA+AG vs GG in UC), or rs10065172 variant (P=0.479 for TT+TC vs CC in CD). [Figure S4](#pone.0080602.s005){ref-type="supplementary-material"} and [Figure S5](#pone.0080602.s006){ref-type="supplementary-material"} showed the funnel plots of dominant models in the three IRGM SNPs.

Discussion {#s4}
==========

IRGM gene, located on chromosome 5q33.1, plays an important role in autophagy. Autophagy has a central function in physiological and pathological processes, involving in innate and adaptive immunity by delivering intracellular pathogens and other antigens. Singh et al demonstrated that IRGM can induce autophagy to eliminate intracellular mycobacterium tuberculosis \[[@B41]\]. Moreover, IRGM 1 -deficient mice have a reduced defense against intracellular pathogens such as *Toxoplasma gondii* and *Listeria monocytogenes* \[[@B42]\]. The presence of bacterial flora is essential for IBD formation in animal models \[[@B43]\]. In addition, autophagy plays an important role in the elimination of apoptotic bodies, and the failure of which might contribute to persistent inflammation in CD \[[@B44]\]. In the recent GWAS meta-analysis, Frank provided strong evidence for the association between IRGM rs7714584 and the risk of IBD (P\<10^-8^, meeting genome-wide significance). Parkes et al \[[@B18]\] found two immediately flanking *IRGM* variants (rs13361189 and rs4958847) associated with CD in two different British cohorts. Thus, *IRGM* may appear to be a good candidate for IBD. However, the results of associations between three *IRGM* variants (rs13361189, rs4958847 and rs10065172) and risk of IBD were contradictory. Therefore, we saw the need to perform pooled analyses with larger sample size by summarizing previous case-control studies in order to understand the association between IRGM variants and IBD risk better.

Our meta-analysis showed significant susceptibility of CD from rs13361189 in the overall population in all genetic contrasts. When stratified by ethnicity, a significant association with rs13361189 was observed in European population, but not in Asians. Similar results were also found between the rs4958847 or rs10065172 variant and risk of CD in overall and European population. It is widely accepted that genetic markers in predisposition to IBD vary across ethnic groups. For instance, nucleotide oligomerization domain 2 (NOD2) polymorphisms have been strongly association with CD in Europeans \[[@B45],[@B46]\], but not in Asian population \[[@B47]-[@B49]\]. These results suggested that rs13361189 and rs4958847 variants might be ethnic population-specific risk factors for CD. However, the lack of association in the Asian population from this study might not be very conclusive owing to the relatively small number of Asian populations used in the analysis (only 2 studies for rs4955847 and 3 studies for rs13361189 in Asian population). Therefore, further studies in Asian populations with larger sample sizes might need to be performed to clarify possible roles of IRGM polymorphisms in CD. Since these SNPs are close to each other, we used 1000 Genomes Pilot sequence data to identify whether these SNPs were in linkage disequilibrium (LD) (r^2^\>0.8). The results showed that rs13361189 was in perfect LD with 2 other IRGM SNPs (rs10065172 and rs1000113, r^2^=1.000) in Europeans. However, rs4958847 was not in LD with 3 other IRGM SNPs (rs13361189, rs10065172 and rs1000113, r^2^=0.304).

Overall, no significant association between rs13361189 or rs4958847variant and susceptibility to UC was found in this meta-analysis in any genetic model. To date, there was lack of association of these two SNPs with UC in all the individual studies. Recently, twin studies and familial clustering of cases suggested that genetic factors were likely to play a more prominent role in CD than in UC \[[@B3]\]. This observation was also supported by the finding that both *NOD2* and *ATG16L1* were associated with CD, but not with UC \[[@B50],[@B51]\].

Heterogeneity was significant for the most comparisons of rs13361189 polymorphism in overall population. To identify the source of heterogeneity, meta-regression and subgroup analysis were carried out. We found that ethnicity was identified as a potential source of between-study heterogeneity. Meta-regression indicated that ethnicity could explain 41.37% of τ^2^. Moreover, the heterogeneity was remarkably decreased among Asian and European population, (CC vs TT: P=0.763, P=0.336, respectively), which may be attributed that IBD is a complex disease and different genetic backgrounds or different environments existed among different ethnicities. Moreover, the sample size could explain 63.28% of τ^2^ under dominant model. In addition, the pooled OR did not change in the sensitivity analysis by excluding studies departed from HWE.

Our meta-analysis significantly increased statistical power by pooling data from different studies, while several limitations should be considered in the present meta-analysis. First, only 2 and 3 studies were performed in Asians for rs4955847 and rs13361189 variants, respectively. Therefore validation of association is required in other population. Second, significant heterogeneity between studies was detected in the current meta-analysis, whereas difference in ethnicity was identified as potential sources of heterogeneity. Third, gene--environment and gene-gene interactions were not analyzed because of insufficient data.

In conclusion, despite these limitations, our meta-analysis still yields statistically significant results. The present data synthesis indicated that rs13361189, rs4958847 and rs10065172 were considered to be risk factors of CD in Europeans but not of UC. In addition, subgroups analysis suggested that this increased risk may be ethno-specific. Further studies in other ethnic groups (e.g. Asians and Africans) are needed to clarify possible roles of *IRGM* polymorphisms in CD or UC. To identify the exact role of *IRGM* polymorphisms in the pathogenesis of CD, more studies such as animal disease modeling are of great importance.
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